NCT05263050 · Interventional trial
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Overall registry status Recruiting
Phase 2
Conditions Carcinoid Tumor, Clear-cell Metastatic Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Neuroendocrine Tumors
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory